Danish Pharmacovigilance Update, 17 March 2011

24 March 2011

In this issue of Danish Pharmacovigilance Update:

  • Reports of serious side effects in Japan from the childhood vaccines Prevenar (PCV7)® and Act-Hib®
  • Reports of serious side effects in France from the childhood vaccine Prevenar13®
  • Indication for Zerit® (stavudine) restricted due to potentially serious side effects
  • Rotarix and RotaTeq® and risk of intussusception
  • Tygacil® (tigecycline) and increased mortality in clinical studies
  • Thalidomide Celgene (thalidomide) and risk of myocardial infarction and thromboembolic events
  • New recommendations for use of Brinavess®
  • The Danish Medicines Agency has received a report of a death in connection with treatment with Concerta® (methylphenidate) for the treatment of ADHD
  • Antidepressants (SSRIs) and deaths or serious side effects in newborns
  • Consumption and side effects from the weight-loss product Regenon®

Download the newsletter in the factbox to the right.